IL186143A0 - Pro-drugs of n-thiazol-2yl-benzamide derivatives - Google Patents

Pro-drugs of n-thiazol-2yl-benzamide derivatives

Info

Publication number
IL186143A0
IL186143A0 IL186143A IL18614307A IL186143A0 IL 186143 A0 IL186143 A0 IL 186143A0 IL 186143 A IL186143 A IL 186143A IL 18614307 A IL18614307 A IL 18614307A IL 186143 A0 IL186143 A0 IL 186143A0
Authority
IL
Israel
Prior art keywords
thiazol
pro
drugs
benzamide derivatives
benzamide
Prior art date
Application number
IL186143A
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL186143A0 publication Critical patent/IL186143A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IL186143A 2005-04-25 2007-09-20 Pro-drugs of n-thiazol-2yl-benzamide derivatives IL186143A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200500594 2005-04-25
DKPA200501331 2005-09-26
DKPA200600445 2006-03-28
PCT/DK2006/000212 WO2006114093A1 (en) 2005-04-25 2006-04-24 Pro-drugs of n-thiazol-2yl-benzamide derivatives

Publications (1)

Publication Number Publication Date
IL186143A0 true IL186143A0 (en) 2008-01-20

Family

ID=36617296

Family Applications (1)

Application Number Title Priority Date Filing Date
IL186143A IL186143A0 (en) 2005-04-25 2007-09-20 Pro-drugs of n-thiazol-2yl-benzamide derivatives

Country Status (13)

Country Link
EP (1) EP1877391A1 (en)
JP (1) JP2008538772A (en)
KR (1) KR20080000607A (en)
AR (1) AR054032A1 (en)
AU (1) AU2006239642A1 (en)
BR (1) BRPI0609565A2 (en)
CA (1) CA2606011A1 (en)
EA (1) EA200702332A1 (en)
IL (1) IL186143A0 (en)
MX (1) MX2007012552A (en)
NO (1) NO20076063L (en)
TW (1) TW200720264A (en)
WO (1) WO2006114093A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010140339A1 (en) * 2009-06-01 2010-12-09 武田薬品工業株式会社 Heterocyclic compound
EP2655377B1 (en) 2010-12-20 2016-03-30 Glenmark Pharmaceuticals S.A. 2-amino-4-arylthiazole compounds as trpa1 antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9823871D0 (en) * 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
DE10348022A1 (en) * 2003-10-15 2005-05-25 Imtm Gmbh New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
TW200524887A (en) * 2003-10-27 2005-08-01 Lundbeck & Co As H N-thiazol-2-yl-benzamide derivatives
RU2007122351A (en) * 2004-11-15 2008-12-20 Тайсо Фармасьютикал Ко. IMINE COMPOUND

Also Published As

Publication number Publication date
AU2006239642A1 (en) 2006-11-02
MX2007012552A (en) 2007-11-16
NO20076063L (en) 2007-11-26
JP2008538772A (en) 2008-11-06
AR054032A1 (en) 2007-05-30
WO2006114093A1 (en) 2006-11-02
CA2606011A1 (en) 2006-11-02
EP1877391A1 (en) 2008-01-16
TW200720264A (en) 2007-06-01
BRPI0609565A2 (en) 2011-10-18
EA200702332A1 (en) 2008-04-28
KR20080000607A (en) 2008-01-02

Similar Documents

Publication Publication Date Title
HRP20150012T1 (en) 39-desmethoxy derivatives of rapamycin
SI1802579T1 (en) Derivatives of 3-arylaminopyridine
HK1129305A1 (en) Substituted 4-amino-pyrrolo-triazine derivatives 4--
HUS2000022I1 (en) Tiglien-3-one derivatives
EP1878727A4 (en) 2-aminoquinazoline derivatives
ZA200710143B (en) Methods of synthesizing 6-alkylaminoquinoline derivatives
ZA200707358B (en) 1-benzylindole-2-carboxamide derivatives
IL192092A0 (en) Aryl-isoxazolo-4-yl-oxadiazole derivatives
GB2424881B (en) Halophenyl derivatives of bisalkylfluorene
PL1954674T3 (en) New n-phenethylcarboxamide derivatives
IL186669A0 (en) Acetylene derivatives
AP2007004282A0 (en) Derivatives of A 1-phenyltriazole as antiparasiticagents
ZA200802421B (en) 1-Acyldihydropyrazol derivatives
ZA200802088B (en) 4-Phenyl-6-substitued-pyrimidine-2-carbonitrile derivatives
IL184841A0 (en) Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives
ZA200805353B (en) Aryl-isoxazol-4-yl-imidazole derivatives
HK1122797A1 (en) Derivatives of pyrido
IL191138A0 (en) Pyrazoloisoquinoline derivatives
ZA200802775B (en) 9-aminocarbonylsubstituted derivatives of glycylcyclines
GB0511410D0 (en) Benzotrizepinone derivatives
IL186143A0 (en) Pro-drugs of n-thiazol-2yl-benzamide derivatives
GB0614154D0 (en) Novel Pyriazine Derivatives
ZA200707966B (en) Pro-drugs of n-thiazol-2yl-benzamide derivatives
ZA200706577B (en) Dihydroimidazothiazole derivatives
HU0500461D0 (en) Pyperazinyl derivatives of alkyl-oxindoles